- Home
- PEW vs GOSS Comparison
PEW vs GOSS Comparison
Compare PEW & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PEW | GOSS |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United States | United States |
| Employees | N/A | 162 |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.6M | 70.8M |
| IPO Year | 2025 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PEW | GOSS |
|---|---|---|
| Price | $2.12 | $11.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $6.75 | $4.19 |
| AVG Volume (30 Days) | 174.4K | ★ 3.2M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $96,449,000.00 | $48,471,000.00 |
| Revenue This Year | $5.25 | N/A |
| Revenue Next Year | $7.96 | $201.64 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3.57 | N/A |
| 52 Week Low | $2.06 | $0.11 |
| 52 Week High | $5.23 | $12.52 |
Technical Indicators
Market Signals| Indicator | PEW | GOSS |
|---|---|---|
| Relative Strength Index (RSI) | 33.27 | 81.80 |
| Support Level | $2.06 | $0.18 |
| Resistance Level | $2.24 | $12.52 |
| Average True Range (ATR) | 0.08 | 1.13 |
| MACD | 0.00 | 0.16 |
| Stochastic Oscillator | 16.67 | 92.00 |
Price Performance
Historical ComparisonAbout PEW GrabAGun Digital Holdings Inc.
GrabAGun Digital Holdings Inc is a multi-brand eCommerce retailer of firearms, ammunition and related accessories. The Company's firearm products are ordered and paid for by customers online through the Company's eCommerce site and mobile app and are delivered to them on-premises through their choice of federal firearm licensed dealers nationwide. The Company's network of localized firearm dealers perform background checks on firearms purchasers and complete sales forms as mandated by federal and state firearm regulations.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).